BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19688296)

  • 1. Pharmacokinetic analysis of etoposide distribution after administration directly into the fourth ventricle in a piglet model.
    Sandberg DI; Crandall KM; Koru-Sengul T; Padgett KR; Landrum J; Babino D; Petito CK; Solano J; Gonzalez-Brito M; Kuluz JW
    J Neurooncol; 2010 Mar; 97(1):25-32. PubMed ID: 19688296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy administration directly into the fourth ventricle in a new piglet model. Laboratory Investigation.
    Sandberg DI; Crandall KM; Petito CK; Padgett KR; Landrum J; Babino D; He D; Solano J; Gonzalez-Brito M; Kuluz JW
    J Neurosurg Pediatr; 2008 May; 1(5):373-80. PubMed ID: 18447671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and pharmacokinetic analysis of methotrexate administered directly into the fourth ventricle in a piglet model.
    Sandberg DI; Solano J; Petito CK; Mian A; Mou C; Koru-Sengul T; Gonzalez-Brito M; Padgett KR; Luqman A; Buitrago JC; Alam F; Wilkerson JR; Crandall KM; Kuluz JW
    J Neurooncol; 2010 Dec; 100(3):397-406. PubMed ID: 20440538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy administration directly into the fourth ventricle in a nonhuman primate model.
    Sandberg DI; Peet MM; Johnson MD; Cole P; Koru-Sengul T; Luqman AW
    J Neurosurg Pediatr; 2012 May; 9(5):530-41. PubMed ID: 22546032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose MTX110 (soluble panobinostat) safely administered into the fourth ventricle in a nonhuman primate model.
    Sandberg DI; Kharas N; Yu B; Janssen CF; Trimble A; Ballester LY; Patel R; Mohammad AS; Elmquist WF; Sirianni RW
    J Neurosurg Pediatr; 2020 May; 26(2):127-135. PubMed ID: 32357333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase-contrast cerebrospinal fluid flow magnetic resonance imaging in qualitative evaluation of patency of CSF flow pathways prior to infusion of chemotherapeutic and other agents into the fourth ventricle.
    Patel RP; Sitton CW; Ketonen LM; Hou P; Johnson JM; Romo S; Fletcher S; Shah MN; Kerr M; Zaky W; Rytting ME; Khatua S; Sandberg DI
    Childs Nerv Syst; 2018 Mar; 34(3):481-486. PubMed ID: 29170836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infusion of 5-Azacytidine (5-AZA) into the fourth ventricle or resection cavity in children with recurrent posterior Fossa Ependymoma: a pilot clinical trial.
    Sandberg DI; Yu B; Patel R; Hagan J; Miesner E; Sabin J; Smith S; Fletcher S; Shah MN; Sirianni RW; Taylor MD
    J Neurooncol; 2019 Jan; 141(2):449-457. PubMed ID: 30460634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours.
    Fleischhack G; Reif S; Hasan C; Jaehde U; Hettmer S; Bode U
    Br J Cancer; 2001 Jun; 84(11):1453-9. PubMed ID: 11384092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a limited sampling model to determine etoposide area under the curve.
    Lum BL; Lane KJ; Synold TW; Goram A; Charnick SB; Sikic BI
    Pharmacotherapy; 1997; 17(5):887-90. PubMed ID: 9324178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial.
    Sandberg DI; Rytting M; Zaky W; Kerr M; Ketonen L; Kundu U; Moore BD; Yang G; Hou P; Sitton C; Cooper LJ; Gopalakrishnan V; Lee DA; Thall PF; Khatua S
    J Neurooncol; 2015 Oct; 125(1):133-41. PubMed ID: 26255071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic approach to compare oral and i.v. administration of etoposide.
    Würthwein G; Krümpelmann S; Tillmann B; Real E; Schulze-Westhoff P; Jürgens H; Boos J
    Anticancer Drugs; 1999 Oct; 10(9):807-14. PubMed ID: 10587290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance.
    Lum BL; Kaubisch S; Fisher GA; Brown BW; Sikic BI
    Cancer Chemother Pharmacol; 2000; 45(4):305-11. PubMed ID: 10755319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence study of two formulations of etoposide in advanced lung cancer patients.
    Li D; Liu L
    Int J Clin Pharmacol Ther; 2015 Jun; 53(6):474-9. PubMed ID: 25828637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of target analytes in various biofluids using a postcolumn infused-internal standard method combined with matrix normalization factors in liquid chromatography-electrospray ionization mass spectrometry.
    Liao HW; Tsai IL; Chen GY; Lu YS; Lin CH; Kuo CH
    J Chromatogr A; 2014 Sep; 1358():85-92. PubMed ID: 25022483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular access device placement in the fourth ventricle to treat malignant fourth ventricle brain tumors: technical note.
    Sandberg DI; Kerr ML
    Childs Nerv Syst; 2016 Apr; 32(4):703-7. PubMed ID: 26597683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of grapefruit juice intake on etoposide bioavailability.
    Reif S; Nicolson MC; Bisset D; Reid M; Kloft C; Jaehde U; McLeod HL
    Eur J Clin Pharmacol; 2002 Oct; 58(7):491-4. PubMed ID: 12389073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated doses of oral etoposide in the treatment of patients with aids-related kaposi sarcoma: a clinical and pharmacologic study to improve therapeutic index.
    Sprinz E; Caldas AP; Mans DR; Cancela A; DiLeone L; Dalla Costa T; Schwartsmann G
    Am J Clin Oncol; 2001 Apr; 24(2):177-84. PubMed ID: 11319295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
    Li X; Choi JS
    Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence investigation of high-dose etoposide and etoposide phosphate in lymphoma patients.
    Reif S; Kingreen D; Kloft C; Grimm J; Siegert W; Schunack W; Jaehde U
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):134-40. PubMed ID: 11561779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of etoposide with intravenous drug administration in children and adolescents.
    Kato Y; Nishimura S; Sakura N; Ueda K
    Pediatr Int; 2003 Feb; 45(1):74-9. PubMed ID: 12654074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.